Lipoprotein(a) concentration does not differ between sexes in healthy offspring of patients with premature myocardial infarction

Journal of Cardiovascular Medicine

Volumn 12, Issue 7, 2011, Pages 482-486

  Barra, Silvia ^a   Cuomo, Vittoria ^b   Silvestri, Nunzia ^a   Materazzi, Crescenzo ^a   Vitagliano, Giancarlo ^a   Capozzi, Giovanbattista ^b   Caruso, Silvio ^a   Gaeta, Giovanni ^a,d   Trevisan, Maurizio ^c  

^a CARDARELLI HOSPITAL   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c Nevada System of Higher Education   (United States)

^d Nevada System of Higher Education ^*  (Italy)

Author keywords

family history; lipoprotein(a); parental myocardial infarction; sex

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); FAMILY HISTORY; FEMALE; HEART INFARCTION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREMATURE MYOCARDIAL INFARCTION; PRESCHOOL CHILD; PREVALENCE; PROGENY; SCHOOL CHILD; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGE OF ONSET; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ITALY; LIPOPROTEIN(A); MALE; MYOCARDIAL INFARCTION; PEDIGREE; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES; UP-REGULATION; YOUNG ADULT;

EID: 79958760236     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328346d367     Document Type: Article

References (54)

1. Bennet A, Di Angelantonio E, Erqou S, Eiriksdottir G, Sigurdsson G, Woodward M, et al. Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospectivedata.ArchInternMed2008;168:598-608. (Pubitemid 351468395)
2. Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, White IR, et al., Emerging Risk Factors Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 2009; 302:412-423.
3. Hoefler G, Harnoncourt F, Paschke E, Mirtl W, Pfeiffer KH, Kostner GM. Lipoprotein Lp(a) A risk factor for myocardial infarction. Arteriosclerosis 1988; 8:398-401.
4. Srinivasan SR, Dahlen GH, Jarpa RA, Webber LS, Berenson GS. Racial (black-white) differences in serum lipoprotein(a) distribution and its relation to parental myocardial infarction in children. The Bogalusa Heart Study. Circulation 1991; 84:160-167.
5. Kostner GM, Czinner A, Pfeiffer KH, Bihari-Varga M. Lipoprotein (a) concentrations as risk indicators for atherosclerosis. Arch Dis Child 1991; 66:1054-1056.
6. Shaukat N, de Bono DP, Jones DR. Like father like son? Sons of patients of European or Indian origin with coronary artery disease reflect their parents' risk factor patterns. Br Heart J 1995; 74:318-323.
7. Routi T, Rönnemaa T, Jokinen E, Viikari J, Niinikoski H, Leino A, et al. Correlation of toddlers' serum lipoprotein(a) concentration with parental values and grandparents' coronary heart disease: the STRIP baby study. Acta Paediatr 1996; 85:407-412. (Pubitemid 26140261)
8. Bihari-Varga M, Kostner G, Czinner A. Lp(a) and the risk of coronary heart disease. Eur J Epidemiol 1992; 8 (Suppl 1):33-35.
9. Vella JC, Jover E. Relation of lipoprotein(a) in 11-19 year-old adolescent to parental cardiovascular heart disease. Clin Chem 1993; 39:477-480. (Pubitemid 23099015)
10. Marques A, Mendoza S, Carrasco H, Hamer T, Glueck CJ. High Lp(a) in children from kindreds with parental premature myocardial infarction. Pediatr Res 1993; 34:670-674. (Pubitemid 23312801)
11. Dirisamer A, Windhalm K. Lipoprotein(a) as a potent risk indicator for early cardiovascular disease. Acta Paediatr 2002; 91:1313-1317. (Pubitemid 36174055)
12. Obisesan TO, Aliyu MH, Adediran AS, Bond V, Maxwell CJ, Rotimi CN. Correlates of serum lipoprotein (A) in children and adolescents in the United States. The third National Health Nutrition and Examination Survey (NHANES-III). Lipids Health Dis 2004; 3:29.
13. Gaeta G, Cuomo S, Capozzi G, Foglia MC, Barra S, Madrid A, et al. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction. Nutr Met Cardiovasc Dis 2008; 18:492-496.
14. Klausen CI, Beisiegel U, Menzel H-S, Rosseneu M, Nicaud V, Faergemann O. Apo(a) phenotypes and Lp(a) concentrations in offspring of men with and without myocardial infarction. The EARS Study. Arterioscler Thromb Vasc Biol 1995; 15:1001-1008.
15. Jenner JL, Ordovas JM, Lamon-Fava S, Schaefer MM, Wilson PW, Castelli WP, et al. Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study. Circulation 1993; 87:1135-1141. (Pubitemid 23110386)
16. Schreiner PJ, Heiss G, Tyroler HA, Morrisett JD, Davis CE, Smith R. Race and gender differences in the association of Lp(a) with carotid artery wall thickness. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol 1996; 16:471-478. (Pubitemid 26084323)
17. De Simone M, Verrotti A, Cappa M, Iughetti L, Di Cesare E, Palumbo M, et al. Lipoprotein (a) in childhood: correlations with family history of cardiovascular disease. J Endocrinol Invest 2003; 26:414-419. (Pubitemid 36896323)
18. Taimela S, Viikari JS, Porkka KV, Dahlen GH. Lipoprotein (a) levels in children and young adults: the influence of physical activity. The Cardiovascular Risk in Young Finns Study. Acta Paediatr 1994; 83:1258-1263.
19. Baroni S, Scribano D, Valentini P, Zuppi C, Ranno O, Giardina B. Serum apolipoprotein A1, B, CII, CIII, E, and lipoprotein (a) levels in children. Clin Biochem 1996; 29:603-605. (Pubitemid 26398916)
20. Gómez Gerique JA, Porres A, Ló pez Martinez D, Alvarez Sala LA, Blazquez E, Montoya MT, et al. Levels of lipoprotein(a) and plasma lipids in Spanish children aged from 4 to 18 years. Acta Paediatr 1996; 85:38-42. (Pubitemid 26045233)
21. Chu NF, Makowski L, Chang JB, Wang DJ, Liou SH, Shieh SM. Lipoprotein profiles, not anthropometric measures, correlate with serum lipoprotein(a) values in children: the Taipei Children Heart Study. Eur J Epidemiol 2000; 16:5-12. (Pubitemid 30186759)
22. Schulpis KH, Karikas GA, Gavrili S, Georgala S. Evaluation of serum lipoprotein(a) in Greek schoolchildren. Acta Paediatr 2001; 90:225-226. (Pubitemid 32222811)
23. Wang W, Lee ET, Alaupovic P, Blackett P, Blevins KS. Correlation between lipoprotein(a) and other risk factors for cardiovascular disease and diabetes in Cherokee Indians: the Cherokee Diabetes Study. Ann Epidemiol 2005; 15:390-397. (Pubitemid 40544943)
24. Souki-Rincón A, Urdaneta J, Mengual E, Torres D, Cano-Peñaloza R, García-Camacho D, et al. Increased levels of lipoprotein (a) are related to family risk factors of cardiovascular disease in children and adolescents from Maracaibo, Venezuela. Am J Ther 2008; 15:403-408.
25. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al. National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110:227-239. (Pubitemid 38924592)
26. Bagust A, Walley T. An alternative to body mass index for standardizing body weight for stature. QJM 2000; 93:589-596.
27. Aasvee K, Kurvinen E, Jordania R, Jauhiainen M, Sundvall J. Lipoprotein parameters in relation to other risk factors of atherosclerosis in adults and newborns: Tallinn Young Family Study. Scand J Clin Lab Invest 2004; 64:245-253. (Pubitemid 38803109)
28. Rifai N, Heiss G, Doetsch K. Lipoprotein(a) at birth, in blacks and whites. Atherosclerosis 1992; 92:123-129.
29. Bailleul S, Couderc R, Rossignol C, Fermanian J, Boutouchent F, Farnier MA, et al. Lipoprotein(a) in childhood: relation with other atherosclerosis risk factors and family history of atherosclerosis. Clin Chem 1995; 41:241-245.
30. Boomsma DI, Kempen HJ,Gevers Leuven JA, Havekes L, de Knijff P, Frants RR. Genetic analysis of sex and generation differences in plasma lipid, lipoprotein, and apolipoprotein levels in adolescent twins and their parents. Genet Epidemiol 1996; 13:49-60. (Pubitemid 26085373)
31. Middelberg RPS, Spector TD, Swaminathan R, Snieder H. Genetic and environmental influences on lipids, lipoproteins, and apolipoproteins: effects of menopause. Arterioscler Thromb Vasc Biol 2002; 22:1142-1147. (Pubitemid 34764865)
32. Chen TJ, Ji CY, Hu YH. Genetic and environmental influences on serum lipids and the effects of puberty: a Chinese twin study. Acta Paediatr 2009; 98:1029-1036.
33. Utermann G. The mysteries of lipoprotein(a). Science 1989; 246:904-910. (Pubitemid 20010500)
34. Albers JJ, Taggart HM, Applebaum-Bowden D, Haffner S, Chesnut CHJ 3rd, Hazzard WR. Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol. Biochim Biophys Acta 1984; 795:293-296. (Pubitemid 14006617)
35. Crook D, Sidhu M, Seed M, O'Donnell M, Stevenson JC. Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid. Atherosclerosis 1992; 92:41-47.
36. Henriksson P, Angelin B, Berglund L. Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma. J Clin Invest 1992; 89:1166-1171.
37. Kim CJ, Min YK, Ryu WS, Kwak JW, Ryoo UH. Effects of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy. Arch Intern Med 1996; 156:1693-1700. (Pubitemid 26287126)
38. Zmuda JM, Thompson PD, Cickenson R, Baussermann LL. Testosterone decreases lipoprotein(a) in men. Am J Cardiol 1996; 77:1244-1247. (Pubitemid 26186973)
39. Marcovina SM, Lippi G, Bagatell CJ, Bremner WJ. Testosterone-induced suppression of lipoprotein(a) in normal men: relation to basal lipoprotein(a) level. Atherosclerosis 1996; 122:89-95.
40. Hislop MS, St Clair Gibson A, Lambert MI, Noakes TD, Marais AD. Effects of androgen manipulation on postprandial triglyceridaemia, low-density lipoprotein particle size and lipoprotein(a) in men. Atherosclerosis 2001; 159:425-432. (Pubitemid 33127256)
41. Christodoulakos GE, Lambrinoudaki IV, Panoulis CP, Papadias CA, Kouskouni EE, Creatsas GC. Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women. Gynecol Endocrinol 2004; 18:244-257. (Pubitemid 38746359)
42. Bayrak A, Aldemir DA, Bayrak T, Corakçi A, Dursun P. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women. Arch Gynecol Obstet 2006; 274:289-296. (Pubitemid 44127293)
43. Stramba-Badiale M. Postmenopausal hormone therapy and the risk of cardiovascular disease. J Cardiovasc Med 2009; 10:303-309.
44. Cobbaert C, Deprost L, Muelder P, Rombaut K, Gijsels G, Kesteloot H. Pubertal serum lipoprotein(a) and its correlates in Belgian schoolchildren. Int J Epidemiol 1995; 24:78-87.
45. Schriewer H, Assmann G, Sandkamp M, Schulte H. The relationship of lipoprotein (a) (Lp(a)) to risk factors of coronary heart disease: initial results of the prospective epidemiological study on company employees in Westfalia. J Clin Chem Clin Biochem 1984; 22:591-596. (Pubitemid 14002314)
46. Brown SA, Hutchinson R, Morrisett J, Boerwinkle E, Davis CE, Gotto AM Jr, et al. Plasma lipid, lipoprotein cholesterol, and apoproteins distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1993; 13:1139-1158. (Pubitemid 23239911)
47. Matthews KA, Crawford SL, Chae CU, Everson-Rose SA, Sowers MF, Sternfeld B, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol 2009; 54:2366-2373.
48. Laurier D, Chau NP, Segond P. Cholesterol and other cardiovascular risk factors in a working population in Ile-de-France (France): first results of the PCV-METRA study. Eur J Epidemiol 1992; 8:693-701.
49. Mercuro G, Deidda M, Pirasa A, Cadeddu Dessalvi C, Maffei C, Rosano GMC. Gender determinants of cardiovascular risk factors and diseases. J Cardiovasc Med 2010; 11:207-220.
50. Haffner SM, Mykkanen L, Gruber KK, Rainwater DL, Laakso M. Lack of association between sex hormones and Lp(a) concentrations in American and Finnish men. Arterioscler Thromb 1994; 14:19-24.
51. Denti L, Pasolini G, Ablondi F, Valenti G. Correlation between plasma lipoprotein Lp(a) and sex hormone concentrations: a cross-sectional study in healthy males. Horm Metab Res 1994; 26:602-608. (Pubitemid 24381121)
52. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001; 86:724-731. (Pubitemid 32207487)
53. Noyan V, Yucel A, Sagsoz N. The association of androgenic sex steroids with serum lipid levels in postmenopausal women. Acta Obstet Gynecol Scand 2004; 83:487-490. (Pubitemid 38534770)
54. Lambrinoudaki I, Christodoulakos G, Rizos D, Economou E, Argeitis J, Vlachou S, et al. Endogenous sex hormones and risk factors for atherosclerosis in healthy Greek postmenopausal women. Eur J Endocrinol 2006; 154:907-916. (Pubitemid 43997731)